Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 20 Melanoma 7 Sarcoma 3 Neoplasms 3 Lymphoma 3 Uveal Melanoma 2 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Melanoma, Cutaneous Malignant 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Immunotherapy 1 Hyperthermia 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Melanoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Immunotherapy × Dacarbazine × 1 year × Clear all

NCT04225390 2026-02-10

PROMIT

University of Erlangen-Nürnberg Medical School

Phase 2 Completed

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡